Chiltern Names Chair
Executive Summary
Chiltern has named Richard Pilnik chair, replacing current chair, Nick Thornton. Pilnik joined the company’s board of directors in 2015 and prior to Chiltern, he was executive vice president (VP) of its commercial solutions division. Previously he also held various positions at Eli Lilly including group VP and chief marketing officer; president, Europe, Middle East and Africa; and area VP of Latin America and Canada.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.